Maximising the impact of KET Biotechnology

On 15-16 November 2016, Project coordinator Dr. Aurelio Hidalgo and Dr. Michael Lappe fom partner QIAGEN Aarhus were honoured to take part in the European Commission’s second Workshop on “Maximising the Impact of KET Biotechnology”.

In line with the goals of Open Innovation, Open Science and Open to the World, the workshop gathered a range of academic and industrial project beneficiaries representing 21 KET Biotechnology projects funded through Horizon 2020, representatives from the European Association for Bio-industries (EuropaBio) and the European Federation of Biotechnology (EFB), delegates from jurisdictions leading in biotechnology (USA, China, Korea and Japan), an expert on standardisation in synthetic biology, representatives of the Bio-based Industries’ Joint Undertaking and representatives of the European Commission.

Discussions focused on ongoing European research and innovation biotechnology projects and their future added value, thereby providing an opportunity for project partners to show actual and potential progress towards expected impacts, as well as a diversity of scientific, industrial and market difficulties and challenges in modern biotechnology.

Dr. Hidalgo and Dr. Lappe presented the objectives of the MetaFluidics project and how we propose to overcome a number of current bottlenecks through innovative metagenomics technologies.

For more information: